Ovariectomy aggravates nifedipine-induced flushing of tail skin in mice.
Flushing is one of the most common vasodilation-related adverse effects associated with Ca(2+) channel antagonist treatment. This symptom is known to occur more frequently in women than men. The present study aimed at investigating the effect of ovariectomy on nifedipine-induced flushing in mice. Ovariectomy markedly increased the tail skin temperature, a parameter of skin flushing, induced by nifedipine at a dose showing no influence on blood pressure. This event was blocked by estradiol replacement. Estrogen withdrawal is, therefore, included in the risk factors for nifedipine-induced flushing and this risk is lessened by estrogen replacement.